Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Timolol Maleate Gel in Healthy Adults vs Infants
NCT06813807Phase 1Completed
- Sponsor
- Auson Pharmaceuticals
- Start
- Jun 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of timolol maleate gel + placebo in infantile hemangioma (IH), sponsored by Auson Pharmaceuticals. Primary endpoints: Maximum Steady State Plasma Concentration, Area Under the Plasma Concentration-Time Curve from Time Zero to Time t at Steady State and 2 more. Started Jun 2024; status: completed.
02
Drugs
timolol maleate gel + placebo
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT06813807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06813807.